Epidemiology and risk factors for recurrence in biliary source bloodstream infection episodes in oncological patients.

biliary source bloodstream infection cholangitis empirical treatment mortality recurrence

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
23 Aug 2023
Historique:
medline: 23 8 2023
pubmed: 23 8 2023
entrez: 23 8 2023
Statut: aheadofprint

Résumé

We aimed to describe the characteristics and outcomes of biliary source bloodstream infections (BSIs) in oncological patients. Secondarily, we analyzed risk factors for recurrent BSI episodes. All episodes of biliary source BSIs in oncological patients were prospectively collected (2008-2019) and retrospectively analyzed. Logistic regression analyses were performed. A rule to stratify patients into risk groups for recurrent biliary source BSI was conducted. Four hundred biliary source BSIs were documented in 291 oncological patients. The most frequent causative agents were

Identifiants

pubmed: 37610217
doi: 10.1128/spectrum.02142-23
pmc: PMC10580831
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0214223

Références

Support Care Cancer. 1995 Nov;3(6):414-7
pubmed: 8564346
Dig Dis Sci. 2012 Oct;57(10):2693-6
pubmed: 22543845
Ann Transl Med. 2021 May;9(9):769
pubmed: 34268382
Clin Microbiol Infect. 2022 Jul;28(7):975-982
pubmed: 35066206
PLoS One. 2014 Sep 19;9(9):e107993
pubmed: 25238395
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:90-103
pubmed: 18154532
Clin Infect Dis. 2001 May 15;32 Suppl 2:S94-103
pubmed: 11320450
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Clin Infect Dis. 2020 Mar 3;70(6):1068-1074
pubmed: 31321410
BMC Infect Dis. 2021 Jul 2;21(1):636
pubmed: 34215207
PLoS One. 2020 Aug 28;15(8):e0237260
pubmed: 32857755
J Antimicrob Chemother. 2012 Jun;67(6):1508-13
pubmed: 22408140
Infect Dis Ther. 2017 Mar;6(1):69-83
pubmed: 28160269
Bone Marrow Transplant. 2020 Mar;55(3):603-612
pubmed: 31570779
J Infect. 2017 Feb;74(2):172-178
pubmed: 27826062
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Gastroenterol Clin North Am. 2021 Jun;50(2):403-414
pubmed: 34024448
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0174421
pubmed: 34843387
J Clin Microbiol. 2017 Aug;55(8):2321-2333
pubmed: 28381609
J Hosp Infect. 2020 Nov;106(3):419-428
pubmed: 32918969
Virulence. 2016 Apr 2;7(3):298-308
pubmed: 26787095
J Clin Gastroenterol. 2004 Apr;38(4):364-7
pubmed: 15087697
Surg Endosc. 2021 Jan;35(1):223-231
pubmed: 31950275
Clin Infect Dis. 1994 Aug;19(2):279-86
pubmed: 7986900
Eur J Clin Microbiol Infect Dis. 2022 Jan;41(1):143-146
pubmed: 34415466
PLoS One. 2019 Mar 1;14(3):e0213209
pubmed: 30822350
Clin Microbiol Rev. 2022 Apr 20;35(2):e0022120
pubmed: 35044203

Auteurs

Ignacio Grafia (I)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Mariana Chumbita (M)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Elia Seguí (E)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Celia Cardozo (C)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Juan Carlos Laguna (JC)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Marta García de Herreros (M)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Nicole Garcia-Pouton (N)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Ana Villaescusa (A)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Cristina Pitart (C)

Microbiology Department, Centre Diagnòstic Biomèdic, Hospital Clínic , Barcelona, Spain.

Verónica Rico-Caballero (V)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Javier Marco-Hernández (J)

Internal Medicine Department, Supportive and Palliative Care in Cancer Unit, Hospital Clínic , Barcelona, Spain.

Carles Zamora (C)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Margarita Viladot (M)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Joan Padrosa (J)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Albert Tuca (A)

Medical Oncology Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Eric Mayor-Vázquez (E)

Medical Intensive Care Unit, Internal Medicine Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Francesc Marco (F)

Microbiology Department, Centre Diagnòstic Biomèdic, Hospital Clínic , Barcelona, Spain.
ISGlobal, Hospital Clínic - Universitat de Barcelona , Barcelona, Spain.

Jose A Martínez (JA)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.
University of Barcelona , Barcelona, Spain.

Josep Mensa (J)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.

Carolina Garcia-Vidal (C)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.
University of Barcelona , Barcelona, Spain.
CIBERINF, CIBER in Infectious Diseases , Barcelona, Spain.

Alex Soriano (A)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.
University of Barcelona , Barcelona, Spain.
CIBERINF, CIBER in Infectious Diseases , Barcelona, Spain.

Pedro Puerta-Alcalde (P)

Infectious Diseases Department, Hospital Clínic-IDIBAPS , Barcelona, Spain.
University of Barcelona , Barcelona, Spain.

Classifications MeSH